Pain

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC30-22

DiraChart Clinical Reference
Protected section 22 of 26
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 22 of 26PreviousNext

17. Common audit and denial risks

System-specific patterns that draw denials and additional documentation requests, with the corrected pattern and the Segment 6 cross-reference. The full catalog lives in Denial Patterns.

Risk

Why it fails

Corrected pattern

Score without context

Intensity number with no location, quality, goal, or function.

Pair the score with location, quality, goal, and functional impact. (See Denial Patterns 6.1.)

Cloned pain narratives

Identical pain language copied visit to visit.

Re-document the visit's actual findings and any change. (6.2.)

“Controlled” without evidence

“Pain controlled” with no scale or function.

Show the score, the goal, and the functional status. (6.3.)

Teaching without measured response

Analgesic or safety teaching with no return-demo or teach-back.

Document topic, method, audience, and mastery percentage. (6.4.)

Notification without outcome

“MD notified” of pain with no orders or response.

Close the loop: time, content, response/orders, follow-through. (6.5.)

Intervention without reassessment

Analgesic given with no post-intervention score.

Record the reassessment score and the functional effect. (6.6.)

No adverse-effect screen on opioids

Opioid regimen with no sedation, respiratory, or bowel assessment.

Screen and document sedation, respiratory status, and bowel function. (6.7.)

Unsupported homebound

“Remains homebound” with no pain-related evidence.

Cite pain-limited ambulation or transfers and the taxing effort. (6.8.)

Wrong or no scale for nonverbal

Self-report assumed for a nonverbal patient.

Use a validated observational scale (for example PAINAD). (6.9.)

Pain present, regimen not evaluated

Documented pain with no evaluation of the analgesic regimen.

Evaluate regimen adherence, effect, and adverse effects. (6.10.)

Section NavigationPart 22 of 26PreviousNext